Travelers' Diarrhea: Resolved and Unresolved Issues
https://doi.org/10.31631/2073-3046-2021-20-3-118-128
Abstract
Relevance. Travel diarrhea is the most common health problem in travelers, affecting up to 70% of travelers, especially when traveling to developing countries. Research and development of scientific and practical approaches to the prevention, risk assessment and treatment of travelers' diarrhea continues to be the focus of attention of specialists in the field of epidemiology, infectious diseases and travel medicine around the world.
Aim of the study: systematization and synthesis of new data on various clinical and epidemiological aspects of travelers' diarrhea.
Conclusion. Analysis of modern scientific literature has made it possible to identify the risks for travelers associated with the direction of travel and the state of their own health. The highest risk of developing traveler's diarrhea (from 20% to 90%) is recorded in people visiting the countries of the Middle East, South and Southeast Asia, Central and South America, and Africa. There is a high risk of developing traveler's diarrhea in children under 4 years of age. The causative agents of acute bacterial intestinal infections can account for up to 80% -90% of all cases of travelers' diarrhea. In most cases, travelers' diarrhea is mild. Seeking medical care is observed from 5% to 15% of cases. For etiotropic therapy, the use of azithromycin, ciprofloxacin and other drugs is recommended. Recommendations for self-management of traveler's diarrhea have been formulated. Pre-trip travel advice will help reduce the risks of travelers' diarrhea.
About the Authors
А. A. Erovichenkov
Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of Russian Academy of Sciences;
Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
Alexander A. Erovichenkov – Dr. Sci. (Med.), Professor, leading researcher Chumakov Federal Scientific Center for Research and Development
Moscow
N. Yu. Pshenichnaya
Federal Budget Institute of Science «Central Research Institute for Epidemiology»
Russian Federation
Russian Federation
Natalia Yu. Pshenichnaya – Dr. Sci. (Med.), Professor, Deputy Director on clinical and analytical work
Moscow
A. A. Ishmukhametov
Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of Russian Academy of Sciences;
Sechenov University
Russian Federation
Russian Federation
Aydar A. Ishmukhametov – Dr. Sci. (Med.), Professor, Corresponding Member of the Russian Academy of Sciences, General Director
Moscow
A. V. Gorelov
Federal Budget Institute of Science «Central Research Institute for Epidemiology»
Russian Federation
Russian Federation
Alexander V. Gorelov – Corresponding Member of the Russian Academy of Sciences, Dr. Sci. (Med.), Professor, Deputy Director for Research
Moscow
V. G. Akimkin
Federal Budget Institute of Science «Central Research Institute for Epidemiology»
Russian Federation
Russian Federation
Vasiliy G. Akimkin – Dr. Sci. (Med.), Academician of the RAS, Professor, Director-in-chief
Moscow
References
1. Lim ML, Wallace MR. Infectious diarrhea in history. Infect Dis Clin North Am. 2004;18(2):261–274. doi: 10.1016/j.idc.2004.01.006.
2. Kean BH. The diarrhea of travelers to Mexico. Summary of five-year study. Ann Intern Med. 1963;59:605–614. doi:10.7326/0003-4819-59-5-605.
3. Rowe B, Taylor J, Bettelheim KA. An investigation of traveller’s diarrhoea. Lancet. 1970;1(7636):1–5. doi:10.1016/s0140-6736(70)90520-9.
4. Sanders JW., Riddle MS., Taylor DN., et al. Epidemiology of Travelers’ Diarrhea in Keystone. Travel Medicine. Elsevier Inc, 2019. Р.187–198. doi.org/10.1016/B978-0-323-54696-6.00018-5.
5. Echeverria P, Sack RB, Blacklow NR, et al. Prophylactic doxycycline for travelers’ diarrhea in Thailand. Further supportive evidence of Aeromonas hydrophila as an enteric pathogen. American Journal of Epidemiology 1984;120(6):912–21. DOI: 10.1093/oxfordjournals.aje.a1139625.
6. Erovichenkov AA., Zvereva NN., Sayfullin MA., Okolot NV. Prevention of Imported Infectious Diseases in Travelers. Epidemiology and Vaccinal Prevention. 2018;17(5):89– 95 (In Russ.). doi.org/10.31631/2073-3046-2018-17-5-89-95.
7. On the state of sanitary and epidemiological well-being of the population in the Russian Federation in 2019: State report. - M .: Federal Service for Supervision of Consumer Rights Protection and Human Welfare, P.220–299 (In Russ.).
8. Rose S., Keystone JS., Hackett P. International Travel Health Guide, 2019 Online Edition. Available at: https://www.travmed.com/pages/health-guide-chapter-1-overviewof-travelers-health. Accessed: 24 Mar 2021.
9. Keystone S. Travel Medicine. 4th ed. Edinburgh London New York Oxford Philadelphia St Louis Sydney:Elsevier Inc.; 2019.
10. Kollaritsch H, Paulke-Korinek M, Wiedermann U. Traveler‘s Diarrhea. Infect Dis Clin North Am. 2012;26(3):691–706. doi:10.1016/j.idc.2012.06.002.
11. Connor BA: Travelers’ diarrhea. Yellow Book: Health Information for Interntional Travel. 2020. CDC website, Available at: https://wwwnc.cdc.gov/travel/yellowbook/2020/preparing-international-travelers/travelers-diarrhea. Accessed: 24 Mar 2021.
12. Steffen R. Epidemiology of traveler’s diarrhea. Clin Infect Dis. 2005;41 Suppl 8:S536–S540. doi:10.1086/432948
13. Soriano-Arandes A, García-Carrasco E, Serre-Delcor N, et al. Travelers’ Diarrhea in Children at Risk: An Observational Study From a Spanish Database. Pediatr Infect Dis J. 2016;35(4):392–395. doi:10.1097/INF.0000000000001049.
14. Kuenzli E, Juergensen D, Kling K, et al. Previous exposure in a high-risk area for travellers’ diarrhoea within the past year is associated with a significant protective effect for travellers’ diarrhoea: a prospective observational cohort study in travellers to South Asia. J Travel Med. 2017;24(5):10.1093/jtm/tax056. doi:10.1093/jtm/tax056.
15. Hyams KC, Bourgeois AL, Merrell BR, et al. Diarrheal disease during Operation Desert Shield. N Engl J Med. 1991;325(20):1423–1428. doi:10.1056/NEJM199111143252006.
16. Baer A, Libassi L, Lloyd JK, et al. Risk factors for infections in international travelers: an analysis of travel-related notifiable communicable diseases. Travel Med Infect Dis. 2014;12(5):525–533. doi:10.1016/j.tmaid.2014.05.005.
17. Schlagenhauf P, Chen LH, Wilson ME, et al. Sex and gender differences in travel-associated disease. Clin Infect Dis. 2010;50(6):826–832. doi:10.1086/650575.
18. Ashkenazi S, Schwartz E. Traveler’s diarrhea in children: New insights and existing gaps. Travel Med Infect Dis. 2020;34:101503. doi:10.1016/j.tmaid.2019.101503.
19. Leung AKC, Leung AAM, Wong AHC, Hon KL. Travelers’ Diarrhea: A Clinical Review. Recent Pat Inflamm Allergy Drug Discov. 2019;13(1):38–48. doi:10.2174/1872213X13666190514105054.
20. Bartelt LA, Guerrant RL Enterobacteriaceae in Mandell Principles and Practice of Infectious Diseases, Elsevier Inc., 2020. - p. 2669–2685.
21. Cabrera-Sosa ., Ochoa TJ. Escherichia coli Diarrhea in Hunter’s Tropical Medicine and Emerging Infectious Diseases, Elsevier Inc., 2020. – р. 481–484.
22. Pires SM, Fischer-Walker CL, Lanata CF, et al. Aetiology-Specific Estimates of the Global and Regional Incidence and Mortality of Diarrhoeal Diseases Commonly Transmitted through Food. PLoS One. 2015;10(12):e0142927. doi:10.1371/journal.pone.0142927.
23. Argudín MÁ, Mendoza MC, Rodicio MR. Food poisoning and Staphylococcus aureus enterotoxins. Toxins. 2010;2(7):1751–1773. doi:10.3390/toxins2071751.
24. Paredes-Paredes M, Flores-Figueroa J, Dupont HL. Advances in the treat-ment of travelers’ diarrhea. Curr Gastroenterol Rep. 2011;13(5):402–407. doi:10.1007/s11894-011-0208-6.
25. Friedman MA, Fleming LE, Fernandez M, et al. Ciguatera fish poisoning: treatment, prevention and management. Mar Drugs. 2008;6(3):456–479. doi:10.3390/md20080022.
26. Stratta P, Badino G. Scombroid poisoning. CMAJ. 2012;184(6):674. doi:10.1503/cmaj.111031.
27. Pavli A, Maltezou HC, Papadakis A, et al. Respiratory infections and gastrointestinal illness on a cruise ship: A three-year prospective study. Travel Med Infect Dis. 2016;14(4):389–397. doi:10.1016/j.tmaid.2016.05.019.
28. Erovichenkov AA Actual aspects of travel medicine. Infectious diseases: news, opinions, training. 2013; 4:27–33 (In Russ.).
29. Giddings SL, Stevens AM, Leung DT. Traveler’s Diarrhea. Med Clin North Am. 2016;100(2):317–330. doi:10.1016/j.mcna.2015.08.017
30. Zvereva NN, Saifullin MA, Sayfullin RF, et al. Epidemiological and etiological features of travel-related febrile illnesses in hospitalized Russian children and adults: A singlecentre, retrospective analysis in Moscow. Travel Med Infect Dis. 2020;34:101447. doi:10.1016/j.tmaid.2019.07.003.
31. Connor BA, Riddle MS. Post-infectious sequelae of travelers’ diarrhea. J Travel Med. 2013;20(5):303–312. doi:10.1111/jtm.12049.
32. WHO position paper on oral rehydration salts to reduce mortality from cholera.2015. Available at: http://www.who.int/cholera/technical/en/. Accessed:24 Mar 2021.
33. Riddle MS, Connor BA, Beeching NJ, et al. Guidelines for the prevention and treatment of travelers’ diarrhea: a graded expert panel report. J Travel Med. 2017;24(suppl_1):S57–S74. doi:10.1093/jtm/tax026.
34. Woerther PL, Andremont A, Kantele A. Travel-acquired ESBL-producing Enterobacteriaceae: impact of colonization at individual and community level. J Travel Med. 2017;24(suppl_1):S29–S34. doi:10.1093/jtm/taw101.
35. Furuya-Kanamori L, Stone J, Yakob L, et al. Risk factors for acquisition of multidrug-resistant Enterobacterales among international travellers: a synthesis of cumulative evidence. J Travel Med. 2020;27(1):taz083. doi:10.1093/jtm/taz083
36. Turunen Katri A, Kantele A. Revisiting travellers’ diarrhoea justifying anti-biotic treatment: prospective study [published online ahead of print, 2020 Dec 28]. J Travel Med. 2020;taaa237. doi:10.1093/jtm/taaa237.
37. Taylor DN, Hamer DH, Shlim DR. Medications for the prevention and treatment of travellers’ diarrhea. J Travel Med. 2017;24(suppl_1):S17–S22. doi:10.1093/jtm/taw097.
38. Nissan B, Lachish T, Schwartz E. The effectiveness of empirical anti-parasitic treatment in returning travellers with persistent abdominal symptoms. J Travel Med. 2018;25(1):10.1093/jtm/tax083. doi:10.1093/jtm/tax083.
39. McFarland LV, Goh S. Are probiotics and prebiotics effective in the prevention of travellers’ diarrhea: A systematic review and meta-analysis. Travel Med Infect Dis. 2019;27:11–19. doi:10.1016/j.tmaid.2018.09.007.
40. Steffen R, Behrens RH, Hill DR, Greenaway C, Leder K. Vaccine-preventable travel health risks: what is the evidence--what are the gaps?. J Travel Med. 2015;22(1):1–12. doi:10.1111/jtm.12171.
41. Dukoral cholera vaccine (inactivated, oral) Available at: https://www.ema.europa.eu/en/medicines/human/EPAR/dukoral. Accessed: 24 Mar 2021.
42. Seo H, Zhang W Development of effective vaccines for enterotoxigenic. Escherichia coli. Lancet Infect Dis. 2020;20(2):150–152. doi:10.1016/S1473-3099(19)30631-0..
43. Walker R, Dull P. Combination vaccine strategies to prevent enteric infections. Vaccine. 2017;35(49 Pt A):6790–6792. doi:10.1016/j.vaccine.2017.06.076.
Review
For citations:
Erovichenkov А.A., Pshenichnaya N.Yu., Ishmukhametov A.A., Gorelov A.V., Akimkin V.G. Travelers' Diarrhea: Resolved and Unresolved Issues. Epidemiology and Vaccinal Prevention. 2021;20(3):118-128. (In Russ.) https://doi.org/10.31631/2073-3046-2021-20-3-118-128
Views:
968
Email this article 